These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19505933)

  • 1. Preclinical testing on insects predicts human haematotoxic potentials.
    Berger J
    Lab Anim; 2009 Oct; 43(4):328-32. PubMed ID: 19505933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro testing for direct immunotoxicity: state of the art.
    Lankveld DP; Van Loveren H; Baken KA; Vandebriel RJ
    Methods Mol Biol; 2010; 598():401-23. PubMed ID: 19967527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematotoxicology: scientific basis and regulatory aspects.
    Gribaldo L
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():111-3. PubMed ID: 12513660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IPCS Collaborative Study on Neurobehavioral Screening. I. Background and genesis.
    MacPhail RC; Tilson HA; Moser VC; Becking GC; Cuomo V; Frantík E; Kulig BM; Winneke G
    Neurotoxicology; 1997; 18(4):925-8. PubMed ID: 9457729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments.
    Arts JH; Muijser H; Jonker D; van de Sandt JJ; Bos PM; Feron VJ
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):125-33. PubMed ID: 18455380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New haemolytic potential assay on an alternative insect model.
    Berger J
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):315-8. PubMed ID: 19627281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IPCS Collaborative Study on Neurobehavioral Screening Methods: II. Protocol design and testing procedures.
    Moser VC; Tilson HA; MacPhail RC; Becking GC; Cuomo V; Frantík E; Kulig BM; Winneke G
    Neurotoxicology; 1997; 18(4):929-38. PubMed ID: 9457730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of in vitro safety studies.
    Suter W
    Curr Opin Chem Biol; 2006 Aug; 10(4):362-6. PubMed ID: 16815733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A search to predict potential for drug-induced cardiovascular toxicity.
    Hamlin RL
    Toxicol Pathol; 2006; 34(1):75-80. PubMed ID: 16507547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordings.
    Rosolen SG; Kolomiets B; Varela O; Picaud S
    Exp Toxicol Pathol; 2008 Jun; 60(1):17-32. PubMed ID: 18294830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal and ocular toxicity in ocular application of drugs and chemicals--part I: animal models and toxicity assays.
    Penha FM; Rodrigues EB; Maia M; Dib E; Fiod Costa E; Furlani BA; Nunes Moraes Filho M; Dreyfuss JL; Bottós J; Farah ME
    Ophthalmic Res; 2010; 44(2):82-104. PubMed ID: 20484950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxicology testing: past and future.
    Luster MI; Gerberick GF
    Methods Mol Biol; 2010; 598():3-13. PubMed ID: 19967502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invertebrates in testing of environmental chemicals: are they alternatives?
    Lagadic L; Caquet T
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):593-611. PubMed ID: 9599707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
    Walker DB
    Toxicol Pathol; 2006; 34(1):94-104. PubMed ID: 16507550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do preclinical testing strategies help predict human hepatotoxic potentials?
    Peters TS
    Toxicol Pathol; 2005; 33(1):146-54. PubMed ID: 15805066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral phenotyping of mice in pharmacological and toxicological research.
    Karl T; Pabst R; von Hörsten S
    Exp Toxicol Pathol; 2003 Jul; 55(1):69-83. PubMed ID: 12940631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
    Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
    Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
    Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.